Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Brigham & Women's Hospital, Boston, MA, USA.
J Assist Reprod Genet. 2023 Mar;40(3):689-690. doi: 10.1007/s10815-023-02712-3. Epub 2023 Jan 13.
The use of preimplantation genetic testing for aneuploidy (PGT-A) in poor responders undergoing assisted reproductive technology has been a topic of debate with controversial results. It is critical to note the denominators used in data presented. Herein, we comment on the results found in the study by Kahraman et al. on the utility of PGT-A in poor responders with a single, good-quality blastocyst.
利用胚胎植入前遗传学检测(PGT-A)对接受辅助生殖技术的反应不良者进行非整倍体检测一直是一个有争议的话题。需要注意的是,所呈现的数据使用的分母。在此,我们对 Kahraman 等人关于在单个优质囊胚的反应不良者中使用 PGT-A 的效用的研究结果进行评论。